Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
65,679
-1,370
-2% -$35.8K 0.61% 53
2026
Q1
$1.88M Buy
67,049
+205
+0.3% +$5.46K 0.79% 50
2025
Q4
$1.66M Sell
66,844
-9,922
-13% -$250K 0.64% 51
2025
Q3
$1.96M Buy
76,766
+1,953
+3% +$48.2K 0.72% 49
2025
Q2
$1.81M Sell
74,813
-131,894
-64% -$3.08M 0.7% 50
2025
Q1
$5.24M Buy
206,707
+8,731
+4% +$228K 1.43% 38
2024
Q4
$5.25M Buy
+197,976
New +$5.37M 1.46% 38

Other funds holding PFE

InvesTrust's PFE Position: Q2 2026 in Review

InvesTrust reduced its Pfizer (PFE) stake by 2% in Q2 2026, selling an estimated $35.8K and leaving 65,679 shares worth $1.58M. The position accounts for 0.61% of the portfolio, ranked #53.

InvesTrust first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.25M in Q4 2024. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • InvesTrust held 65,679 shares of Pfizer worth $1.58M as of Q2 2026.
  • InvesTrust sold 1,370 Pfizer shares in Q2 2026, an estimated $35.8K.
  • Pfizer made up 0.61% of InvesTrust's portfolio in Q2 2026, its #53 holding.
  • InvesTrust first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • InvesTrust's Pfizer position peaked at $5.25M in Q4 2024.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on InvesTrust's 13F filing for Q2 2026, filed 14 Jul 2026.